glucaric acid has been researched along with tyrosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayde, M; Hayn, M; Herkner, K; Lombard, KA; Lubec, G; Pollak, A; Weninger, M; Widness, JA | 1 |
| Huang, X; Katz, SD; Zhang, Q; Zheng, H | 1 |
| Bald, E; Glowacki, R; Nowak, P; Olas, B; Saluk-Juszczak, J; Wachowicz, B | 1 |
| Bailie, GR; Leggett, RE; Levin, R; Li, H; Li, HD; Patadia, H; Schuler, C | 1 |
| Angerosa, M; Cao, G; Dominici, FP; Giani, JF; Toblli, JE | 1 |
| Cao, G; Dominici, FP; Giani, JF; Rivas, C; Toblli, JE | 1 |
2 trial(s) available for glucaric acid and tyrosine
| Article | Year |
|---|---|
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Topics: Administration, Oral; Ascorbic Acid; Blood Cell Count; Drug Therapy, Combination; Erythrocyte Indices; Erythrocyte Transfusion; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Malondialdehyde; Prospective Studies; Tyrosine | 2001 |
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation | 2006 |
4 other study(ies) available for glucaric acid and tyrosine
| Article | Year |
|---|---|
Protective effects of D-glucaro 1,4-lactone against oxidative/nitrative modifications of plasma proteins.
Topics: Blood Proteins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Glucaric Acid; Glutathione; Homocysteine; Humans; Hydrogen Peroxide; Molecular Weight; Nitrites; Oxidation-Reduction; Sulfhydryl Compounds; Tyrosine | 2007 |
Oxidative effect of several intravenous iron complexes in the rat.
Topics: Administration, Intravenous; Animals; Dinitrobenzenes; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron-Dextran Complex; Maltose; Oxidative Stress; Rats; Tissue Distribution; Tyrosine | 2013 |
Nitrosative Stress and Apoptosis by Intravenous Ferumoxytol, Iron Isomaltoside 1000, Iron Dextran, Iron Sucrose, and Ferric Carboxymaltose in a Nonclinical Model.
Topics: Administration, Intravenous; Animals; Apoptosis; Caspase 3; Disaccharides; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron-Dextran Complex; Kidney; Liver; Male; Maltose; Models, Animal; Myocardium; Rats; Tyrosine | 2015 |
Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
Topics: Anemia; Animals; Cardiotonic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Fibrosis; Glucaric Acid; Inflammation; Infusions, Intravenous; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine; Ventricular Remodeling | 2016 |